Medicaid's cuts in Trump's Megabill will hit some drug manufacturers
The president of the United States, Donald Trump, presents a broad legislation of expenses and prosecutors, known as the “Law…
Bristol-Myers Squibb Co.
The best selections of Biotechnology and Farma by JPMorgan for the second half
The low performance of biopharmaceutical actions versus the widest market for a third consecutive year is an opportunity for investors,…
Astrazeneca, Pfizer, Gilead releases cancer medicines data
Attendees walk through the lobby of the annual meeting of the American Society of Clinical Oncology in Chicago. Tim Boyle…
Trump's previous views negotiations in the price of Medicare medications
In a photographic illustration, prescription medications are seen next to a bottle of pill on July 23, 2024 in New…
6 portfolio names committed to making large investments in the United States from Trump 2.0
Many of the largest American companies have pledged to invest billion dollars in the United States since President Donald Trump…
Bristol Myers Squibb (BMY) Q1 2025 profits
File Photo: The Bristol Myers Squibb Research and Development Center in Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023.…
We are lowering our target price of Bristol Myers despite a profit rate
Bristol Myers Squibb and Rosy Outlook's profits on Thursday did not solve persistent problems for actions. But it was enough,…
Trump seeks to change Medicare drug prices negotiations
The president of the United States, Donald Trump, speaks with the media during the annual Easter eggs of the White…
These are the 4 greatest things we are seeing in the stock market next week.
The stock market is directed to Monday with a volatility streak, it seems that it cannot be shaken. What had…
Trump says that pharmaceutical rates are arriving, the actions fall
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters The actions of drug…